Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease.

Sabater L, Guasp M, Ruiz García R, Naranjo Rondán L, Querol L, Martín-Aguilar L, Llarch P, Balasa M, Lladó A, Painous C, Compta Y, Serafim AB, Montini A, Iranzo A, Santamaria Cano J, Dalmau JO, Graus F, Gaig C; Anti-IgLON5 Disease Study Group.